| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A peptide aldehyde that inhibits the proteasome, thus can prevent the degradation of proteins targeted by FBXO25. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A boronic acid derivative that inhibits the 26S proteasome, potentially increasing the levels of proteins marked for degradation by FBXO25. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
A β-lactone that irreversibly inhibits proteasome activity, could lead to accumulation of FBXO25 substrates. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
A specific proteasome inhibitor that covalently binds to and inhibits the chymotrypsin-like activity of the proteasome, affecting FBXO25 function indirectly. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
An inhibitor of NEDD8-activating enzyme, it prevents neddylation, which is necessary for the activity of the cullin-RING ligase complex that includes FBXO25. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
An inhibitor of the ubiquitin-activating enzyme E1, could indirectly affect FBXO25 by disrupting ubiquitin conjugation to target proteins. | ||||||
IU1 | 314245-33-5 | sc-361215 sc-361215A sc-361215B | 10 mg 50 mg 100 mg | $138.00 $607.00 $866.00 | 2 | |
A specific inhibitor of the deubiquitinating enzyme USP14, can affect proteasome-associated deubiquitination that indirectly involves FBXO25 activity. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
A glutarimide that indirectly inhibits the E3 ubiquitin ligase activity of cereblon, a protein that can intersect with FBXO25's pathways. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
A compound that inhibits MDM2, an E3 ubiquitin-protein ligase, which can intersect with FBXO25-mediated ubiquitination processes. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
An antimalarial drug that can alkalize the lysosomal pH, potentially affecting the degradation of proteins that FBXO25 targets for ubiquitination. | ||||||